---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-002381"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T04:50:51.817703+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NeuroOne reports preliminary Q1 FY2025 revenue of $6.2M, up from $1.0M YoY

## Summary
- Preliminary unaudited Q1 FY2025 total revenue $6.2M vs $1.0M in Q1 FY2024.
- Includes $3.0M one-time collaboration revenue from Zimmer Biomet expanded distribution agreement.
- Product revenue $3.2M, up 227% YoY from $1.0M.
- Reiterates FY2025 product revenue guidance $8-10M, product gross margin 47-51%.
- Virtual investor webinar held Jan 10, 2025 at 11am ET.

## SEC filing metadata
- accession: 0001213900-25-002381
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390025002381/0001213900-25-002381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390025002381/ea0225131-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-002381
- JSON: https://secwatch.observer/filing/0001213900-25-002381.json
- Plain text: https://secwatch.observer/filing/0001213900-25-002381.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.